Boston Partners Care Dx, Inc. Transaction History
Boston Partners
- $80.6 Billion
- Q3 2024
A detailed history of Boston Partners transactions in Care Dx, Inc. stock. As of the latest transaction made, Boston Partners holds 375,138 shares of CDNA stock, worth $7.85 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
375,138
Previous 24,289
1444.48%
Holding current value
$7.85 Million
Previous $377,000
3006.37%
% of portfolio
0.01%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CDNA
# of Institutions
218Shares Held
51.1MCall Options Held
97.3KPut Options Held
43.3K-
Black Rock Inc. New York, NY5.29MShares$111 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$94.9 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.15MShares$65.8 Million1.65% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.99MShares$62.6 Million0.89% of portfolio
-
State Street Corp Boston, MA2.04MShares$42.6 Million0.0% of portfolio
About CareDx, Inc.
- Ticker CDNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 53,458,100
- Market Cap $1.12B
- Description
- CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...